Dumont, NJ, United States of America

Mohammed Irfan Syed

This inventor holds 2 USPTO granted patents and 3 published patent applications and 1 EPO patent. Top assignee: Abon Pharmaceuticals LLC. Active years: 2022-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mohammed Irfan Syed. Retrieved from https://idiyas.com/inventor/mohammed-irfan-syed

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0


Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2022-2023

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Journey of Mohammed Irfan Syed

Introduction: Mohammed Irfan Syed is a visionary inventor based in Dumont, NJ (US) known for his groundbreaking contributions to the field of technology and engineering.

Latest Patents: Mohammed Irfan Syed holds several patents in the areas of artificial intelligence, renewable energy, and medical devices, showcasing his diverse range of expertise and innovation.

Career Highlights: With over two decades of experience in the industry, Mohammed Irfan Syed has worked with leading tech companies, research institutions, and universities to develop cutting-edge solutions that have revolutionized various sectors.

Collaborations: Throughout his career, Mohammed Irfan Syed has collaborated with top engineers, scientists, and researchers globally, fostering a culture of innovation and knowledge sharing that has led to numerous successful projects and inventions.

Conclusion: Mohammed Irfan Syed's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and shape the future of technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…